Skip to main content
GLPG
NASDAQ Life Sciences

Bank of America Reduces Stake in Galapagos Below 5% Threshold

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$33.25
Mkt Cap
$2.159B
52W Low
$22.591
52W High
$37.78
52W Position info
47% above low
Off High info
12% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

GLPG sits 47% above its 52-week low of $22.591.

Summary

Bank of America Corporation has reported that its total holding in Galapagos NV fell below the 5% transparency threshold due to the disposal of equivalent financial instruments.


Key Events · Ownership and Investor Activity · GLPG

  • Bank of America Reduces Stake

    Bank of America Corporation's total holding in Galapagos NV (including direct voting rights and equivalent financial instruments) fell below the 5% transparency threshold on March 10, 2026.

  • Current Ownership Level

    Following the disposal of equivalent financial instruments, Bank of America Corporation now holds 3.91% of Galapagos' currently outstanding 65,897,071 shares.


Analysis · GLPG · Life Sciences

This filing indicates that a significant institutional investor, Bank of America Corporation, has reduced its stake in Galapagos NV, falling below the 5% ownership disclosure threshold. While such reductions by institutional investors can be for various reasons, including portfolio rebalancing or liquidity management, it generally signals a decrease in conviction or a shift in investment strategy regarding the company. Investors should note the reduction in institutional ownership.

How filings like this one have moved

In the 30 days to Sep 19, 2026, 29.1% of the 1646 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GLPG was trading at $33.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $22.59 to $37.78. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GLPG - Latest Insights

GLPG
May 06, 2026, 5:19 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $28.81
Real-time Price: $28.49 info
Change: -$0.320 (-1%) info
Market Cap: $1.821B info
GLPG
May 06, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $28.81
Real-time Price: $28.49 info
Change: -$0.320 (-1%) info
Market Cap: $1.821B info
GLPG
Apr 29, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $28.42
Real-time Price: $28.49 info
Change: +$0.070 (+0.25%) info
Market Cap: $1.821B info
GLPG
Mar 31, 2026, 1:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $28.84
Real-time Price: $28.49 info
Change: -$0.350 (-1%) info
Market Cap: $1.821B info
GLPG
Mar 30, 2026, 9:41 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $29.46
Real-time Price: $28.49 info
Change: -$0.970 (-3%) info
Market Cap: $1.821B info